Inhibition of invasiqn and metastasis of pancreatobiliary cancers by HGF/NK4 gene.

HGF/NK4基因抑制胰胆癌的侵袭和转移。

基本信息

  • 批准号:
    12671286
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Pancreatobiliary cancers are highly malignant and its prognosis is poor due to extensive invasion and metastasis of the cancer cells to surrounding tissues or organs. We previously revealed that hepatocyte growth factor (HGF) stimulates cancer invasion and metastasis via its receptor c-met protooncogene. To control invasion and metastasis of these cancers, we created an antagonist, HGF/NK4, and its inhibitory effect on invasion and cancer growth. We examined in this study whether HGF/NK4 gene transfer into the cells results in suppression of the invasion and metastasis or not. Transfection of a plasmid carrying HGF/NK4 gene into a gallbladder cancer cell line, GB-d1, could not suppress invasive nature of the parental GB-dl. An adenovirus vector carrying HGF/NK4 gene, AdCMV. NK4, was purified and used for therapy in a murine model. GB-d1 cells and mesothelial cells infected with the adenovirus vector produced substantial level of NK4 protein. And the invasion and migration of GB-d1 cells was extremely inhibited by the virus. In nude mouse model for peritoneal metastasis of GB-d1 cells, the size of the metastasis tumor was decreased after injection of the virus into peritoneal cavity. We concluded that the adenovirus vector carrying HGF/NK4 gene might be effective to control biliary cancer dissemination or metastasis by induction of HGF/NK4 protein.
胰胆管癌是高度恶性的,并且由于癌细胞向周围组织或器官的广泛侵袭和转移,其预后差。我们先前发现肝细胞生长因子(HGF)通过其受体c-met原癌基因刺激癌症侵袭和转移。为了控制这些癌症的侵袭和转移,我们创建了一种拮抗剂HGF/NK 4,并研究了其对侵袭和癌症生长的抑制作用。本研究旨在探讨HGF/NK 4基因转染对肝癌细胞侵袭和转移的抑制作用。将携带HGF/NK 4基因的质粒转染到胆囊癌细胞系GB-d1中,不能抑制亲本GB-d1的侵袭性。携带HGF/NK 4基因的腺病毒载体AdCMV。纯化NK 4并用于鼠模型中的治疗。用腺病毒载体感染的GB-d1细胞和间皮细胞产生大量水平的NK 4蛋白。病毒对GB-d1细胞的侵袭和迁移能力有明显的抑制作用。在GB-d1细胞裸鼠腹膜转移模型中,腹腔注射病毒后,转移瘤体积缩小。结论:携带HGF/NK 4基因的腺病毒载体可能通过诱导HGF/NK 4蛋白的表达而有效地控制胆管癌的播散或转移。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kuba K., Matsumoto K., Date K., Shimura H., Tanaka M., Nakamura T.: "HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that that suppresses tumor growth and metastasis in micea"Cancer Research. 60. 6737-6743 (200
Kuba K.、Matsumoto K.、Date K.、Shimura H.、Tanaka M.、Nakamura T.:“HGF/NK4 是肝细胞生长因子的四环拮抗剂,是一种血管生成抑制剂,可抑制肿瘤生长和转移
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kuba, Matsumoto, Date, Shimura, Tanaka, Nakamura: "HGF/NK4, a four-kringle antagonists 'of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice"Cancer Res.. 60. 6737-6743 (2000)
Kuba、Matsumoto、Date、Shimura、Tanaka、Nakamura:“HGF/NK4 是肝细胞生长因子的四环拮抗剂,是一种血管生成抑制剂,可抑制小鼠肿瘤生长和转移”Cancer Res.. 60. 6737-6743
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kuba,K.,Matsumoto,K.,Date K.,Shimura H.,Tanaka M.,and Nakamura M.: "HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice."Cancer Research. 60:. 6737-6743 (2000)
Kuba,K.、Matsumoto,K.、Date K.、Shimura H.、Tanaka M. 和 Nakamura M.:“HGF/NK4 是肝细胞生长因子的四环拮抗剂,是一种抑制肿瘤生长的血管生成抑制剂
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIMURA Hideo其他文献

SHIMURA Hideo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIMURA Hideo', 18)}}的其他基金

HGF antagonist (HGF/NK4) gene therapy for pancreatobiliary cancer.
HGF 拮抗剂 (HGF/NK4) 基因治疗胰胆癌。
  • 批准号:
    14571248
  • 财政年份:
    2002
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of invasion induced by hepatocyte growth factor in gallbladder carcinoma cell lines
肝细胞生长因子诱导胆囊癌细胞侵袭的机制
  • 批准号:
    07671400
  • 财政年份:
    1995
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

ICF: A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
ICF:一种安全有效治疗慢性非感染性葡萄膜炎的新型双靶点基因疗法
  • 批准号:
    MR/Z50385X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
Next-generation automation and PAT implementation for QbD and enhanced approaches for cell and gene therapy
QbD 的下一代自动化和 PAT 实施以及细胞和基因治疗的增强方法
  • 批准号:
    10087446
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Collaborative R&D
Longitudinal structural and cognitive functional imaging and outcome prediction in focal epilepsy treated with gene therapy and surgical resection.
基因治疗和手术切除治疗局灶性癫痫的纵向结构和认知功能成像及结果预测。
  • 批准号:
    MR/X031039/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
GeneT: The Gene Therapy CoE at the Center of Portugal
GeneT:葡萄牙中心的基因治疗 CoE
  • 批准号:
    10090933
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    EU-Funded
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
  • 批准号:
    MR/Y019458/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
Developing a gene therapy product to treat pressure ulcers in lower-limb amputees
开发一种基因治疗产品来治疗下肢截肢者的压力性溃疡
  • 批准号:
    2888189
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Studentship
Activation of long non-coding RNA by a gene therapy CRISPR/Cas9 approach to prevent vein graft failure
通过基因治疗 CRISPR/Cas9 方法激活长非编码 RNA 以预防静脉移植失败
  • 批准号:
    EP/X024563/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
SBIR Phase I: Development of an Adjustable Gene Therapy Platform Technology
SBIR 第一阶段:可调节基因治疗平台技术的开发
  • 批准号:
    2240683
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Standard Grant
Exploration novel effects of SHED-TK-derived exosomes on TK/GCV suicide gene therapy
探索SHED-TK衍生的外泌体对TK/GCV自杀基因治疗的新作用
  • 批准号:
    23K15643
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Gene expression profiling of skin ulcers for short-acting in vivo gene therapy
皮肤溃疡的基因表达谱用于短效体内基因治疗
  • 批准号:
    23K19673
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了